Avantium Reports H1 2025 Results

Key highlights
  • Avantium's sugar dehydration unit is operational, producing MMF for FDCA.
  • Sales under offtake agreements are expected to start in Q1 2026.
  • Avantium secured €20M financing and is launching a €65M equity raise.
  • The company has 20 offtake agreements and 7 capacity reservations.

Technical Progress

Avantium has successfully started up its sugar dehydration unit, a crucial component of the FDCA Flagship Plant. This unit converts plant sugars into MMF, an essential intermediate in FDCA production. The company is now moving forward with the commissioning and start-up of the oxidation and purification units.

Commercial Outlook

Sales under existing offtake agreements are anticipated to begin in the first quarter of 2026. Avantium has secured 20 offtake agreements and 7 capacity reservations, indicating strong commercial traction.

Financial Developments

Avantium has obtained €20 million in new financing from the Province of Groningen, Invest-NL, and a consortium of lenders. Additionally, the company is launching a fully committed and underwritten €65 million equity raise, with €12.25 million already secured through cornerstone investments and pre-commitments.

Regulatory and Financial Support

The company has received key regulatory approvals and improved terms on its existing Debt Financing Facilities, which will aid in long-term cash preservation. The Dutch State, represented by the Ministry of Climate Policy and Green Growth, supports Avantium's initiatives, highlighting the importance of their technology in addressing plastic production and waste challenges.

Source: Avantium

chemXplore Weekly

The week’s project milestones and project news from the chemical industry, free every Wednesday.

Free. One email a week. Unsubscribe any time.

Related articles

7 July 2026
Al Baleed Petrochemical joins Carbeau to commercialise Volta CO₂-to-chemicals technology

Becomes strategic partner in a spin-out commercialising an electrochemical route to turn captured CO₂ into glycolic acid and PLGA using renewable electricity; Salalah eyed for first non‑EU plant.

6 July 2026
Avantium spins out Volta into Carbeau, secures €35.2m

Spin-out backed by strategic and financial investors to scale an electrochemical CO₂-to-chemicals platform targeting glycolic acid and compostable PLGA.

13 May 2026
Avantium sells Ray Technology IP to UPM

Sale transfers Ray Technology patents for bio-based MEG/MPG (up to end‑2023). Seller refocuses on FDCA/PEF; €2.7M proceeds used to repay debt (€2.0M) and dismantle pilot (€0.7M).

4 September 2025
Avantium Launches €65 Million Rights Offering

The offering supports Avantium's funding needs until EBITDA break-even in 2027, with cornerstone investments and full underwriting. Commercial operations for PEF start in Q1 2026.